The demographics and prognosis of non-small cell lung cancer patients have changed during the last few decades. We conducted this study to assess the change in demographics and prognosis in resected non-small cell lung cancer patients during a 20-yr single-institution study in Korea. We retrospectively reviewed the medical records of 2,076 non-small cell lung cancer patients who underwent pulmonary resection between 1990 and 2009. Their clinical characteristics and survival were analyzed over a five-year period. With time, the proportions of female, adenocarcinoma, stage IA, and lobectomy patients increased, whereas the proportions of male, squamous cell carcinoma, stage IIIA, and pneumonectomy patients decreased. These demographic changes caused improved prognosis. The five-year survival rate of all patients was 53.9%. The five-year survival rate increased from 31.9% in 1990-1994, to 43.6% in 1995-1999, 51.3% in 2000-2004, and 69.7% in 2005-2009 (P < 0.001). In conclusion, among patients with resected non-small cell lung cancer, the proportions of female, adenocarcinoma, stage IA, and lobectomy patients have increased, and the five-year survival rate has gradually improved during the last 20 yr in Korea. http://dx.doi. org/10.3346/jkms.2012.27.12.1486 • J Korean Med Sci 2012 27: 1486-1490 
INTRODUCTION
Lung cancer is the leading cause of cancer deaths in the Western world as well as in Korea (1) (2) (3) . Non-small cell lung cancer (NSCLC) constitutes more than 80% of lung cancer cases, and surgery remains the only potentially curative treatment for early stage lung cancer. During the last few decades, the clinical profile of NSCLC patients who are candidates for surgical resection has changed dramatically. According to the Japanese Joint Committee for Lung Cancer Registration (JJCLCR), the proportions of patients who are female, have stage IA disease, and have adenocarcinoma have increased, and the five-year survival rate has gradually improved from 47.2% in 1989, to 52.6% in 1994, to 61.4% in 1999, and to 69.6% in 2004 (4-7). As such, it is important to understand the demographics, tumor-related background, and the prognosis by related factors and stage. In addition, determining trends in those parameters will be helpful in developing nation-specific strategies for lung cancer treatment. In this study, we analyzed 20 yr of single-institution data to identify the recent surgical outcomes and trends related to non-small cell lung cancer surgery in Korea.
MATERIALS AND METHODS

Patients
We reviewed the records of 2,076 patients with NSCLC who underwent pulmonary resection at our institute from January 1990 to December 2009. Pathological staging was based on the 2009 TNM classification system (8) . Tumor histology was categorized according to the World Health Organization classification. Lymph node status was assessed according to the system defined by Mountain and Dresler (9) . Lobectomy and systematic lymph node dissection were the procedures of choice, regardless of clinical stage. Patients with stage I-IIIA disease were indicated for surgical resection. All patients were followed either until death or the last follow-up date (December 1, 2011).
Statistical analysis
The duration of survival was defined as the interval between the date of surgery and either the date of death or the last follow-up date. Survival curves were estimated using the KaplanMeier method, and differences in survival were assessed by the log-rank test. In the analysis of pathologic stage and survival, the patients (n = 169) who received induction treatment were http://dx.doi.org/10.3346/jkms.2012.27.12.1486 excluded. A P value less than 0.05 was considered significant. The data were analyzed using SPSS for Windows (Statistical Package for the Social Sciences, SPSS Inc. Chicago, IL, USA).
Ethics statement
The institutional review board of Yonsei University College of Medicine approved this retrospective study (4-2012-0505 ). Informed consent was waived by the board.
RESULTS
Patient characteristics
The 2,076 patients included 558 females and 1,518 males with a median age of 62 yr (range, 10 to 90 yr). The median follow-up Number of cases Fig. 1) , while the proportion of squamous cell carcinomas decreased annually from 56.6% ( (Table 2) .
Trends in survival
The overall five-year survival rate of all patients was 53.9%. The overall survival rate improved over time, increasing from 31.9% in [1990] [1991] [1992] [1993] [1994] The lung cancer incidence in Western countries (North America, Western Europe, Australia) has stabilized over the past decades (10). However, there have been major shifts in the frequencies of the various histological types of lung cancer, with significant increases in the incidence of adenocarcinoma, and a corresponding decrease in the incidence of squamous cell cancer. For example, registry data from the USA indicated that the ratio of squamous carcinomas to adenocarcinomas was approximately 17:1, and by 1995 these two histological types of cancer were nearly equal in incidence. Although lung cancer data are not extensively available for Asian populations, the same pattern of change has been observed (11) . In Taiwan, a study of over 10,000 cases over the period from 1970 to 1993 showed that the incidence of squamous carcinoma decreased from 46.4% to 36.2% in men, whereas adenocarcinoma increased from 30% to 36% in men and from 50.7% to 64.8% in women, such that adenocarcinoma has now become the most common cancer cell type (12) . Similar patterns were found in Singapore, Korea, Hong Kong and Japan (13) (14) (15) (16) . This study also showed a similar pattern with surgically resected lung cancer cases and this shift in the distribution of cancer types was prominent after the mid2000s (Fig. 1) .
The prognosis of surgical resection of NSCLC was not promising. Despite "curative resection, " more than 70% of patients with NSCLC in one study experienced recurrence (17) . The five- year survival rate after resection was 42.6% according to Naruke et al. (18) and 41.4% according to van Rens et al. (19) . However, it is not surprising that postoperative survival is changing with each decade based on the date of resection, histology, and the distribution of stages.
There have been a few reports focusing on the change in surgical results over time (Table 4) 
